New solution to help providers deliver improved patient outcomes, optimize care delivery, enhance clinical and operational decision making, accelerate clinical research and time-to-market, and more Industry-leading customers like Anthem, Health Cataly
AUSTIN, Texas & HAMILTON, Ontario--(BUSINESS WIRE)--Triumvira Immunologics (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients wi
Flora Growth’s CEO Luis Merchan is named Chairman of the Board of Directors. Tim Leslie, Chairman of Flora’s Advisory Board, will join the Flora Board of Directors and audit committee. Changes to the Board of Directors signal the Company’s mov
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting as psychoneuroplastogens
First patient dosed in VITALIZE Phase 2B trial in relapsed/refractory DLBCL Metastatic bladder cancer cohort data from Phase 2 basket trial to be presented at late-breaking symposium at AACR Phase 2B Avalon trial in advanced ovarian cancer to star
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that in response to the uncertainty of potash supply from Eastern Europe it plans to increase potash production capability to approximately 15 million tonnes in 202
Flexible platform helps companies in retail, hospitality, facilities management, transportation and other industries simplify their most complex operational challenges RALEIGH, N.C.--(BUSINESS WIRE)--mpro5 Inc., the leader in workflow management and auto
MONTREAL--(BUSINESS WIRE)--Soundbite Medical Solutions Inc. (SBMS), a medical device company leveraging its proprietary shock wave technology for the interventional treatment of calcific occlusive peripheral and coronary arterial diseases, today announced
VICTORIA, British Columbia--(BUSINESS WIRE)--$IPA #DHA--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service therapeutic antibody discovery and development, today announced financial res
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™” is pleased to announce that Doug Drysdale, Cybin’s Chief Ex
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.